A trial design for evaluation of empiric programming of implantable cardioverter defibrillators to improve patient management
JM Morgan, LD Sterns, JL Hanson… - Current Controlled Trials …, 2004 - Springer
The delivery of implantable cardioverter defibrillator (ICD) therapy is sophisticated and
requires the programming of over 100 settings. Physicians tailor these settings with the …
requires the programming of over 100 settings. Physicians tailor these settings with the …
Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention
F Streitner, T Herrmann, J Kuschyk, S Lang… - PLoS …, 2013 - journals.plos.org
Background Emerging interest is seen in the paradox of defibrillator shocks for ventricular
tachyarrhythmia and increased mortality risk. Particularly in patients with dilated …
tachyarrhythmia and increased mortality risk. Particularly in patients with dilated …
Long‐Term Outcomes Among a Nationwide Cohort of Patients Using an Implantable Cardioverter‐Defibrillator: UMBRELLA Study Final Results
S Briongos‐Figuero, A García‐Alberola… - Journal of the …, 2021 - Am Heart Assoc
Background Large‐scale studies describing modern populations using an implantable
cardioverter‐defibrillator (ICD) are lacking. We aimed to analyze the incidence of arrhythmia …
cardioverter‐defibrillator (ICD) are lacking. We aimed to analyze the incidence of arrhythmia …
Guideline-directed medical therapy and the risk of death in primary prevention defibrillator recipients
M Dhande, G Rangavajla, A Canterbury… - Clinical …, 2022 - jacc.org
Background Contemporary guideline-directed medical therapy (GDMT) confers a significant
mortality benefit for patients with heart failure with reduced ejection fraction (HFrEF), as …
mortality benefit for patients with heart failure with reduced ejection fraction (HFrEF), as …
Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 …
Aims Primary prevention implantable cardioverter defibrillators (ICDs) are established
therapy for reducing mortality in patients with left ventricular systolic dysfunction and …
therapy for reducing mortality in patients with left ventricular systolic dysfunction and …
Time to Shock the System: Moving Beyond the Current Paradigm for Primary Prevention Implantable Cardioverter‐Defibrillator Use
FM Merchant, WC Levy, DB Kramer - Journal of the American …, 2020 - Am Heart Assoc
(ICDs) play a crucial role in the treatment of patients at heightened risk of sudden cardiac
death (SCD) caused by ventricular arrhythmias. The use of ICDs for primary prevention is …
death (SCD) caused by ventricular arrhythmias. The use of ICDs for primary prevention is …
The effect of duration of follow-up and presence of competing risk on lifespan-gain from implantable cardioverter defibrillator therapy: who benefits the most?
CE Raphael, JA Finegold, AJ Barron… - European heart …, 2015 - academic.oup.com
Background In at-risk patients with left ventricular dysfunction, implantable cardioverter
defibrillators (ICDs) prolong life. Implantable cardioverter defibrillators are increasingly …
defibrillators (ICDs) prolong life. Implantable cardioverter defibrillators are increasingly …
[HTML][HTML] Predictors of appropriate therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death
I Ahmed, WB Nelson, CM House, DWX Zhu - Heart International, 2010 - ncbi.nlm.nih.gov
The purpose of this study was to evaluate predictors of appropriate therapy in patients with
implantable cardioverter-defibrillators (ICD) for primary prevention of sudden cardiac death …
implantable cardioverter-defibrillators (ICD) for primary prevention of sudden cardiac death …
Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients
MD Smit, PFHM Van Dessel, M Rienstra… - Europace, 2006 - academic.oup.com
Aims Atrial fibrillation (AF) is often present in patients with left ventricular dysfunction who
receive an implantable cardioverter-defibrillator (ICD). The purpose of this study was to …
receive an implantable cardioverter-defibrillator (ICD). The purpose of this study was to …
The Low Energy Safety Study (LESS): rationale, design, patient characteristics, and device utilization
DE Mann, RC Klein, SL Higgins, RA Freedman… - American Heart …, 2002 - Elsevier
Background A 10-J energy safety margin has traditionally been used in programing
implantable cardioverter defibrillators (ICDs). The Low Energy Safety Study (LESS) tests the …
implantable cardioverter defibrillators (ICDs). The Low Energy Safety Study (LESS) tests the …